Cohen Jonathan, Reed William, Foster Matthew W, Kahmke Russel R, Rocke Daniel J, Puscas Liana, Cannon Trinitia Y, Lee Walter T
Hadassah University Medical Center Jerusalem Israel.
Department of Head and Neck Surgery and Communication Sciences Duke University Health System Durham North Carolina USA.
Laryngoscope Investig Otolaryngol. 2022 Nov 28;8(1):113-119. doi: 10.1002/lio2.962. eCollection 2023 Feb.
Pharyngocutaneous fistula (PCF) and salivary leaks are well known complications of head and neck surgery. The medical management of PCF has included the use of octreotide without a well-defined understanding of its therapeutic mechanism. We hypothesized that octreotide induces alterations in the saliva proteome and that these alterations may provide insight into the mechanism of action underlying improved PCF healing. We undertook an exploratory pilot study in healthy controls that involved collecting saliva before and after a subcutaneous injection of octreotide and performing proteomic analysis to determine the effects of octreotide.
Four healthy adult participants provided saliva samples before and after subcutaneous injection of octreotide. A mass-spectrometry based workflow optimized for the quantitative proteomic analysis of biofluids was then employed to analyze changes in salivary protein abundance after octreotide administration.
There were 3076 human, 332 , 102 , and 42 protein groups quantified in saliva samples. A paired statistical analysis was performed using the generalized linear model (glm) function in edgeR. There were and ~300 proteins that had a < .05 between the pre- and post-octreotide groups ~50 proteins with an FDR-corrected < .05 between pre- and post-groups. These results were visualized using a volcano plot after filtering on proteins quantified by 2 more or unique precursors. Both human and bacterial proteins were among the proteins altered by octreotide treatment. Notably, four isoforms of the human cystatins, belonging to a family of cysteine proteases, that had significantly lower abundance after treatment.
This pilot study demonstrated octreotide-induced downregulation of cystatins. By downregulation of cystatins in the saliva, there is decreased inhibition of cysteine proteases such as Cathepsin S. This results in increased cysteine protease activity that has been linked to enhanced angiogenic response, cell proliferation and migration that have resulted in improved wound healing. These insights provide first steps at furthering our understanding of octreotide's effects on saliva and reports of improved PCF healing.
咽皮肤瘘(PCF)和唾液漏是头颈外科手术中众所周知的并发症。PCF的药物治疗包括使用奥曲肽,但对其治疗机制的了解并不明确。我们假设奥曲肽会引起唾液蛋白质组的改变,这些改变可能有助于深入了解改善PCF愈合的作用机制。我们在健康对照者中进行了一项探索性初步研究,包括在皮下注射奥曲肽前后收集唾液,并进行蛋白质组学分析以确定奥曲肽的作用效果。
四名健康成年参与者在皮下注射奥曲肽前后提供唾液样本。然后采用基于质谱的工作流程,该流程针对生物流体的定量蛋白质组分析进行了优化,以分析奥曲肽给药后唾液蛋白质丰度的变化。
在唾液样本中定量了3076个人类、332个、102个和42个蛋白质组。使用edgeR中的广义线性模型(glm)函数进行配对统计分析。在奥曲肽注射前后组之间,有300种蛋白质的P值<0.05,在前后组之间有50种蛋白质经FDR校正后的P值<0.05。在通过2个或更多独特前体定量的蛋白质上进行过滤后,使用火山图对这些结果进行可视化。人类和细菌蛋白质都在奥曲肽处理后发生改变的蛋白质中。值得注意的是,属于半胱氨酸蛋白酶家族的人类胱抑素的四种同工型在治疗后丰度显著降低。
这项初步研究证明了奥曲肽诱导胱抑素下调。通过下调唾液中的胱抑素,对半胱氨酸蛋白酶如组织蛋白酶S的抑制作用减弱。这导致半胱氨酸蛋白酶活性增加,而半胱氨酸蛋白酶活性增加与血管生成反应增强、细胞增殖和迁移有关,从而促进了伤口愈合。这些见解为进一步了解奥曲肽对唾液的影响以及PCF愈合改善情况提供了第一步。